Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,591	13,820	12,946	11,482	8,080	8,955
Market Cap Growth	10.04%	6.75%	12.75%	42.11%	-9.78%	-9.54%
Enterprise Value	13,021	12,878	12,124	10,966	7,766	8,528
Last Close Price	136.74	136.50	131.76	119.44	85.17	95.85
PE Ratio	40.41	40.49	51.85	74.32	90.18	21.99
Forward PE	16.15	18.15	21.34	22.53	24.55	22.30
PS Ratio	5.44	5.87	6.86	7.71	7.13	8.56
PB Ratio	5.02	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	5.08	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	25.55	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	23.81	23.21	33.20	33.83	31.50	39.19
PEG Ratio	1.27	0.37	0.37	0.37	0.37	0.37
EV/Sales Ratio	5.19	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	24.68	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	26.09	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	24.63	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.18	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.84	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.93	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.70	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	18.63	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.88	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.20	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	13.39%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.67%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.42%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	2.58%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	3.91%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	0.05%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q